Longest follow up trial of Merck\'s Keytruda sets new standard for five year survival in lung cancer httpbit.ly2WFhUNLÂ lungcancer oncology pharma

Longest follow up trial of Merck's #Keytruda sets new standard for five year survival in lung #cancer http://bit.ly/2WFhUNL  #lungcancer #oncology #pharma

Longest follow up trial of Merck's #Keytruda sets new standard for five year survival in lung #cancer http://bit.ly/2WFhUNL  #lungcancer #oncology #pharma

More From BioPortfolio on "Longest follow up trial of Merck's #Keytruda sets new standard for five year survival in lung #cancer http://bit.ly/2WFhUNL  #lungcancer #oncology #pharma"